
-
Gezora wins Prix de Diane in Graffard masterpiece
-
Pogacar wins first Dauphine ahead of Tour de France title defence
-
Trump due in Canada as G7 confronts Israel-Iran crisis
-
Kubica steers Ferrari to third consecutive 24 Hours of Le Mans
-
French Open champ Alcaraz ready for Queen's after Ibiza party
-
India a voice for Global South at G7, says foreign minister
-
Sinner had 'sleepless nights' after dramatic French Open final loss
-
Gattuso named new Italy coach after Spalletti sacking
-
Relatives lament slow support, wait for remains after India crash
-
Israel vows to make Iran pay 'heavy price' as fighting rages on
-
Macron, on Greenland visit, berates Trump for threats against the territory
-
Qualifier Maria completes fairytale run to Queen's title
-
Gattuso named new Italy coach
-
Tens of thousands rally in Dutch Gaza protest
-
Israel-Iran conflict: latest developments
-
Israel keeps up Iran strikes after deadly missile barrage
-
Ex-president Sarkozy stripped of France's top honour after conviction
-
Iran missiles kill 10 in Israel in night of mutual attacks
-
'This is a culture': TikTok murder highlights Pakistan's unease with women online
-
Families hold funerals for Air India crash victims
-
US Fed set to hold rates steady in the face of Trump pressure
-
Sober clubbing brews fresh beat for Singapore Gen Z
-
Cummins flags Australia shake-up after WTC defeat as Ashes loom
-
Mexico down Dominican Republic to open Gold Cup defence
-
Pochettino defends Pulisic omission: 'I'm not a mannequin'
-
Panthers on brink of Stanley Cup repeat after 5-2 win over Oilers
-
Messi denied late winner in Club World Cup opener
-
Trump flexes military might at parade as protests sweep US
-
New-look Man City crave winning feeling at Club World Cup
-
Big tech on a quest for ideal AI device
-
Guest list for G7 summit tells of global challenges
-
Macron to Greenland in show of support after Trump threats
-
'Mass grave' excavation to finally start at Irish mother and baby home
-
'Hidden treasure': Rare Gandhi portrait up for UK sale
-
Fearless Chiefs plot raid on Crusaders fortress in Super Rugby final
-
US Open leader Burns eyes first major title at historic Oakmont
-
Messi gets Club World Cup under way in Miami
-
Burns grabs US Open lead with Scott and Spaun one back
-
Future of Uncrewed Airpower on Display at Paris Air Show
-
Russell grabs dazzling Canadian GP pole then jokes at Verstappen's expense
-
Thompson in six-way tie for LPGA lead in Michigan
-
Inter striker Taremi stranded in Iran amid conflict: club
-
No.1 Scheffler well back as pal Burns fights for US Open title
-
Trump's military parade kicks off as protests sweep US
-
PSG excitement for Club World Cup trumps fatigue ahead of Atletico clash
-
Burns and Spaun share US Open lead through nine holes of third round
-
Toulon power past Castres and into Top 14 semi-final
-
Russell delivers sensational lap to take pole at Canadian GP
-
Anti-Trump protesters rally across US ahead of military parade
-
Iran activates air defences, Israelis told to shelter as both sides trade strikes

US announces new funds for mRNA vaccines, fast tracks bird flu tests
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it was accelerating bird flu testing, as fears loom of another pandemic.
In all, 67 people in the United States have been infected with avian influenza since the outbreak began last year, including an elderly man who died in Louisiana earlier this month.
While the virus has not conclusively been found to spread from person to person, the amount of bird flu circulating among animals and humans has alarmed scientists, because it might combine with seasonal influenza and mutate into a more transmissible form -- potentially triggering a deadly pandemic.
"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra.
Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. This technology trains the body's immune system using genetic instructions, an approach proven highly effective against Covid. Moderna received $176 million for this effort in July 2024.
The United States also maintains a stockpile of millions of H5N1 vaccine doses based on traditional methods, targeting earlier virus strains but expected to offer solid protection if needed, experts say.
Meanwhile, the Centers for Disease Control and Prevention announced that all positive influenza A tests, especially from hospitalized patients, will be fast-tracked for further testing to check for H5N1.
"H5N1 is a subtype of influenza A," said Nirav Shah, a senior CDC official. Subtyping determines whether the virus is a common seasonal strain or a novel version like H5N1, he explained.
Such testing should ideally be completed within 24 hours, he added, to help researchers understand how the infection occurred, identify potential exposures, and protect health workers.
Until the Louisiana fatality, US cases had been relatively mild. Globally, however, nearly half of the 954 human H5N1 infections recorded since 2003 have been fatal, according to the World Health Organization.
Concerns have also been raised about incoming President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., a vocal critic of vaccines, especially mRNA technology -- widely regarded as a key tool against future pandemics.
He is also a known fan of raw milk, which has repeatedly been found to be contaminated with bird flu from infected dairy cows.
T.Suter--VB